Ignite Creation Date:
2024-05-06 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03344965
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2017-10-31
Brief Title:
Olaparib in Metastatic Breast Cancer
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Beth Israel Deaconess Medical Center
Organization Data
Organization:
Beth Israel Deaconess Medical Center
Class:
OTHER
Study ID:
17-428
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beth Israel Deaconess Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Nadine Tung
Responsible Party Title:
Prinicipal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beth Israel Deaconess Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dana-Farber Cancer Institute | OTHER |
| Johns Hopkins University | OTHER |
| AstraZeneca | INDUSTRY |